Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2708-2026

Arterial Line Kit 20ga x 6, REF: 400115A Recall

Arterial Line Kit 20ga x 6, REF: 400115A

FDA recall Class I

Ongoing

FDA lists this Class I recall for Arterial Line Kit 20ga x 6, REF: 400115A. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2708-2026
Recall classification
Class I
Enforcement status
Ongoing
Initiation date
Jun 1, 2026
FDA report date
Jul 22, 2026
Quantity in commerce
440
Distribution
See key details
FDA cause
Material/Component Contamination

What is being recalled?

Arterial Line Kit 20ga x 6, REF: 400115A

Affected model & UDI checker

Search the exact identifiers published for Z-2708-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
400115AArterial Line Kit 20ga x 6, REF: 400115ACheck source noticeNot specified
FDA code information

REF/UDI-DI Box:Unit/Lot(Expiration): 400115A/20886333212884:00886333212880/11655174(7/19/2027), 11655183(7/19/2027), 11655185(7/19/2027), 11659131(7/19/2027);

View the original FDA recall notice

Why was this product recalled?

Kits containing Lidocaine HCL Injection USP 1% 10mg/mL 5mL ampules subject to another recall recalled due to not meeting release criteria for sterility.

What actions did Argon Medical Devices, Inc. take?

On 6/1/2026, correction notices were sent to customers who were asked to do the following: 1) Do not use the affected Lidocaine vials included in affected Kits and Sets in scope of this notice 2) Review your inventory for any product covered by this Medical Device Notification. If any items from the affected lot are identified: - Place a copy of this notice with the affected product - Apply the enclosed stickers to the packaging (kit) to clearly identify the item and remind users to discard affected lidocaine. 3) At the point of use, upon opening the kit, discard the affected Lidocaine vials in accordance with your facility's procedures. 4) Obtain Lidocaine separately through your facility pharmacy and prepare / administer it per institutional protocols prior to the procedure. 5) Complete and return the response form via email [email protected]

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology